Cargando…

The Protective Effect of Vanadium on Cognitive Impairment and the Neuropathology of Alzheimer’s Disease in APPSwe/PS1dE9 Mice

Alzheimer’s disease (AD) is a widely distributed neurodegenerative disease characterized clinically by cognitive deficits and pathologically by formation of amyloid-β (Aβ) plaque and neurofibrillary tangles (NFTs) in the brain. Vanadium is a biological trace element that has a function to mimic insu...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Zhijun, Han, Shuangxue, Zhu, Huazhang, Hu, Xia, Li, Xiaoqian, Hou, Chaofan, Wu, Chong, Xie, Qingguo, Li, Nan, Du, Xiubo, Ni, Jiazuan, Liu, Qiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077345/ https://www.ncbi.nlm.nih.gov/pubmed/32210760 http://dx.doi.org/10.3389/fnmol.2020.00021

Ejemplares similares

Inhibiting NLRP3 Inflammasome Activation by CY-09 Helps to Restore Cerebral Glucose Metabolism in 3×Tg-AD Mice
por: Han, Shuangxue, et al.
Publicado: (2023)

Effect of Increased IL-1β on Expression of HK in Alzheimer’s Disease
por: Han, Shuangxue, et al.
Publicado: (2021)

Long-Term Caloric Restriction Attenuates β-Amyloid Neuropathology and Is Accompanied by Autophagy in APPswe/PS1delta9 Mice
por: Müller, Luisa, et al.
Publicado: (2021)

Alzheimer’s Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound
por: He, Zhijun, et al.
Publicado: (2021)

Cardiomyocyte Contractile Dysfunction in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease
por: Turdi, Subat, et al.
Publicado: (2009)

Mitochondrial dynamics changes with age in an APPsw/PS1dE9 mouse model of Alzheimer’s disease
por: Xu, Lin-Lin, et al.
Publicado: (2017)

The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD
por: Yao, Jinyi, et al.
Publicado: (2023)

High fat diet exacerbates Alzheimer's disease-related pathology in APPswe/PS1 mice
por: Thériault, Peter, et al.
Publicado: (2016)

YXQN Reduces Alzheimer’s Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice
por: Wang, Xiaowan, et al.
Publicado: (2017)

Protective effects of luteolin against amyloid beta-induced oxidative stress and mitochondrial impairments through peroxisome proliferator-activated receptor γ-dependent mechanism in Alzheimer's disease
por: He, Zhijun, et al.
Publicado: (2023)

Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice
por: Papazoglou, Anna, et al.
Publicado: (2017)

Zn(2+) Aggravates Tau Aggregation and Neurotoxicity
por: Li, Xuexia, et al.
Publicado: (2019)

The Protective Effect of Icariin on Mitochondrial Transport and Distribution in Primary Hippocampal Neurons from 3× Tg-AD Mice
por: Chen, Yijing, et al.
Publicado: (2016)

Genome-Wide Analysis of miRNA Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease
por: Luo, Hongxue, et al.
Publicado: (2014)

Microvascular ultrastructural changes precede cognitive impairment in the murine APPswe/PS1dE9 model of Alzheimer’s disease
por: Kelly, Patricia, et al.
Publicado: (2017)

Andrographolide promotes hippocampal neurogenesis and spatial memory in the APPswe/PS1ΔE9 mouse model of Alzheimer’s disease
por: Arredondo, Sebastian B., et al.
Publicado: (2021)

Mechanisms Mediating the Protective Effects of Eicosapentaenoic Acid in Brain of the APPswePS1dE9 Alzheimer's Mouse Model
por: Yavari, Mahsa, et al.
Publicado: (2022)

Transcriptome analysis of fasudil treatment in the APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer’s disease
por: Yan, Hailong, et al.
Publicado: (2022)

Gender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer's Disease
por: Papazoglou, Anna, et al.
Publicado: (2016)

Mitochondrial biogenesis mediated by melatonin in an APPswe/PS1dE9 transgenic mice model
por: Song, ChaoYuan, et al.
Publicado: (2018)

Sex-specific hippocampal metabolic signatures at the onset of systemic inflammation with lipopolysaccharide in the APPswe/PS1dE9 mouse model of Alzheimer’s disease
por: Agostini, Alessandra, et al.
Publicado: (2020)

Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer’s disease-related pathologies in APPswe/PS1dE9 transgenic mice
por: Tsai-Teng, Tzeng, et al.
Publicado: (2016)

The Impact of Bdnf Gene Deficiency to the Memory Impairment and Brain Pathology of APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease
por: Rantamäki, Tomi, et al.
Publicado: (2013)

Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
por: Ettcheto, Miren, et al.
Publicado: (2021)

Reactive astrocytes as treatment targets in Alzheimer's disease—Systematic review of studies using the APPswePS1dE9 mouse model
por: Smit, Tamar, et al.
Publicado: (2021)

Utilization of APPswe/PS1dE9 Transgenic Mice in Research of Alzheimer's Disease: Focus on Gene Therapy and Cell-Based Therapy Applications
por: Malm, Tarja, et al.
Publicado: (2011)

Analysis of differential plaque depositions in the brains of Tg2576 and Tg-APPswe/PS1dE9 transgenic mouse models of Alzheimer disease
por: Kim, Tae-Kyung, et al.
Publicado: (2012)

Tocotrienol Rich Fraction Supplementation Modulate Brain Hippocampal Gene Expression in APPswe/PS1dE9 Alzheimer’s Disease Mouse Model
por: Wan Nasri, Wan Nurzulaikha, et al.
Publicado: (2019)

Cattle encephalon glycoside and ignotin injection improves cognitive impairment in APPswe/PS1dE9 mice used as multitarget anti-Alzheimer’s drug candidates
por: Gao, Ya, et al.
Publicado: (2015)

Amyloid pathology induces dysfunction of systemic neurotransmission in aged APPswe/PS2 mice
por: Oh, Se Jong, et al.
Publicado: (2022)

Longitudinal follow-up of autophagy and inflammation in brain of APPswePS1dE9 transgenic mice
por: François, Arnaud, et al.
Publicado: (2014)

Curcumin regulates insulin pathways and glucose metabolism in the brains of APPswe/PS1dE9 mice
por: Wang, Pengwen, et al.
Publicado: (2017)

nAChRs gene expression and neuroinflammation in APPswe/PS1dE9 transgenic mouse
por: D’Angelo, Chiara, et al.
Publicado: (2021)

Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer’s Disease
por: Allué, José Antonio, et al.
Publicado: (2016)

Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice
por: Mellott, Tiffany J., et al.
Publicado: (2017)

Beneficial Effect of a Selective Adenosine A(2A) Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease
por: Faivre, Emilie, et al.
Publicado: (2018)

Retinal Levels of Amyloid Beta Correlate with Cerebral Levels of Amyloid Beta in Young APPswe/PS1dE9 Transgenic Mice before Onset of Alzheimer's Disease
por: Mei, Xi, et al.
Publicado: (2020)

The influence of GAPT extraction on synapse loss of APPswe/PS1dE9 transgenic mice via adjusting Bcl-2/Bax balance
por: Shi, Jing, et al.
Publicado: (2018)

Corrigendum: Amyloid pathology induces dysfunction of systemic neurotransmission in aged APPswe/PS2 mice
por: Oh, Se Jong, et al.
Publicado: (2022)

Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways
por: Ettcheto, Miren, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cck2uh1024ci633q48oeautrsa